We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ROCKB:BXROCKWOOL A/S Class B Analysis

Data as of 2026-03-15 - not real-time

DKK 186.01

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Rockwool A/S is trading well below its 20‑day (≈203) and 50‑day (≈213) simple moving averages, signaling a bearish price trend, while the 14‑day RSI sits near 29, indicating oversold conditions. Technical momentum is further weakened by a bearish MACD histogram and a price that remains above the identified support at roughly 177 DKK but far from the 226.75 DKK resistance. Fundamentally, the stock appears dramatically overvalued – a trailing P/E of over 250 versus an industry average of ~29 and a DCF‑derived fair value of just 5.2 DKK – and it delivers modest profit margins (≈0.7% net) despite solid gross profitability. The dividend yield of 2.23% is supported by an extremely low payout ratio (~8%), suggesting sustainability, but the company’s growth is flat (‑0.3% revenue YoY) and its return metrics are weak. Recent news of a corporate share‑class conversion and an upgrade by UBS to “buy” on margin provide a minor positive catalyst, yet the overall valuation gap and bearish technical setup dominate the outlook.
Investors should therefore treat ROCKB as a high‑priced, low‑growth industrial with limited upside potential in the near to medium term, while the dividend remains a modest, sustainable income stream.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages indicating bearish momentum
  • RSI in oversold territory suggesting potential short‑term bounce
  • Increasing volume despite thin overall trading activity

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Persistently high valuation relative to earnings and DCF fair value
  • Flat revenue growth and low net margins
  • Sustained dividend with very low payout ratio

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Extreme overvaluation that is unlikely to be justified by fundamentals
  • Weak profitability and minimal ROE/ROA
  • High price volatility and limited upside beyond current support levels

Key Metrics & Analysis

Financial Health

Revenue Growth-0.30%
Profit Margin0.72%
P/E Ratio251.4
ROE0.96%
ROA9.86%
Debt/Equity10.07
P/B Ratio1.9
Op. Cash FlowDKK610.0M
Free Cash FlowDKK91.0M
Industry P/E29.1

Technical Analysis

TrendBearish
RSI28.9
SupportDKK 176.91
ResistanceDKK 226.75
MA 20DKK 203.64
MA 50DKK 212.59
MA 200DKK 243.42
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueDKK 5.16
GradeOvervalued
TypeValue
Dividend Yield2.23%

Risk Assessment

Beta0.42
Volatility39.74%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.